← SynDRA
ETODOLAC
SynDRA canonical compound SYN0001234 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | PTGS2 |
|---|
| Mechanism of action | Cyclooxygenase inhibitor |
|---|
| Indication | osteoarthritis | rheumatoid arthritis |
|---|
| Disease area | rheumatology |
|---|
All known targets
Mechanisms of action (all sources)
- Cyclooxygenase inhibitor
- PTGS2 INHIBITOR
Drug classes
- Cyclooxygenase Inhibitors
- Nonsteroidal Anti-inflammatory Drug
- Analgesics
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Antirheumatic Agents
- Cyclooxygenase 2 Inhibitors
- Enzyme Inhibitors
- Peripheral Nervous System Agents
- Sensory System Agents
ATC classes
- M01A · ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
Cross-references
Synonyms
- etodine
- etodolic acid
- hypen
- Etodolic acid
- Etodolaco
- (rs)-etodolic acid
- Eccoxolac
- Edolan
- Flancox
- Lodin xl
- Napilac
- Tedolan
- Ultradol
- Zedolac
- AY-24,236
- AY-24-236
- AY-24236
- NIH-9918
- NSC-282126
- Ebretin
- Etolyn
- Etopan xl
- Lodine
- Lodine sr
- Lodine xl
- Ramodar
- Lodine XL
- Etodolacum
- Etodolacum [INN-Latin]
- Etodolaco [INN-Spanish]
- CCRIS 3923
- 2-(1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)acetic acid
- CHEMBL622
- NSC 282126
- 1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid
- 1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acid
- 1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid
- Pyrano[3,4-b]indole-1-acetic acid, 1,8-diethyl-1
Reported adverse events
- Alopecia
- Angioedema
- Anxiety
- Arrhythmia
- Asthenia
- Asthma
- Bronchitis
- Chills
- Conjunctivitis
- Cyst
- Cystitis
- Dyspepsia
Look up ETODOLAC in the interactive SynDRA portal →